Immune duo shows promise in blocking Post-Transplant virus
NCT ID NCT04934527
First seen May 13, 2026 · Last updated May 25, 2026 · Updated 1 time
Summary
This study tested a new way to prevent CMV infection in 42 kidney transplant patients who already had the virus. Researchers gave patients CMV-fighting antibodies and checked if a specific immune cell (called LTgdVd2neg CD16+) could help protect them. The goal was to see if this approach could prevent CMV infection without standard antiviral drugs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CMV INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hopital Pellegrin
Bordeaux, 33000, France
Conditions
Explore the condition pages connected to this study.